4.7 Article

Discharge of breast cancer patients to primary care at the end of hospital follow-up: A cross-sectional survey

Journal

EUROPEAN JOURNAL OF CANCER
Volume 49, Issue 8, Pages 1836-1844

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2013.01.016

Keywords

Breast cancer; Follow-up; General practice; Cross-sectional survey

Categories

Ask authors/readers for more resources

Aim: The present study explored (a) the discharge of breast cancer patients to primary care by specialists, at the end of hospital follow-up and (b) the experiences and views of general practitioners (GPs) regarding transfer of follow-up to the primary care setting. Methods: A cross-sectional survey was performed by sending a self-administered questionnaire to 960 GPs working in the three northern provinces of the Netherlands. Data were analysed using descriptive statistics. Results: Of 949 eligible questionnaires, 502 were returned, providing an adjusted response rate of 53%. In the year before the survey took place, one or more patients aged >60 years, and 5 years after breast-conserving therapy, were discharged to 22% of GPs (n = 112) for follow-up. According to 56% of these GPs, transfer of follow-up was communicated by the hospital. The initiative to arrange follow-up visits and mammography appointments was mainly taken by patients. In this survey, 40% of GPs (n = 200) were willing to accept exclusive responsibility for follow-up earlier than 5 years after completion of active treatment. Perceived barriers in current and future primary care-based follow-up included: communication with breast cancer specialists, patients' preference for specialist follow-up, GPs' oncology knowledge and skills and the organisation of follow-up in general practice. Conclusions: Primary care-based follow-up might be improved if breast cancer specialists discharge patients more actively to their GPs. Survivorship care plans are needed to facilitate communication across the primary/secondary interface and with patients. Training of GPs and developing administrative tools may be helpful in arranging follow-up care and using guidelines in general practice. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Oncology

Reply to: Measuring longitudinal adherence to screening needs international standards

Lilu Ding, Marcel J. W. Greuter, Guido Van Hal, Geertruida H. de Bock

BREAST (2023)

Article Oncology

Quality of life after treatment with immune checkpoint inhibitors for lung cancer; the impact of age

E. Suazo-Zepeda, P. C. Vinke, M. A. Heuvelmans, G. Sidorenkov, T. J. N. Hiltermann, G. H. de Bock

Summary: The study aims to evaluate the association between the age of lung cancer patients treated with ICIs and changes in Health-Related Quality-of-Life (HRQoL). It also compares the HRQoL scores of ICI-treated patients with normative data from an age-matched non-cancer general population.

LUNG CANCER (2023)

Article Dermatology

Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study

Marjolijn S. Haisma, Mathanhy Logendran, Jens Bos, Bert V.d. Vegt, Barbara Horvath, Stijn DE Vos, Geertruida H. D. E. Bock, Eelko Hak, Emoke Racz

Summary: This study investigated the association between hydrochlorothiazide use and skin cancer incidence. It found a clear association between high cumulative hydrochlorothiazide use and the risk of different types of skin cancer.

ACTA DERMATO-VENEREOLOGICA (2023)

Article Multidisciplinary Sciences

Predicted versus CT-derived total lung volume in a general population: The ImaLife study

Hendrik Wisselink, Danielle J. D. A. Steerenberg, Mieneke Rook, Gert-Jan H. Pelgrim, Marjolein Heuvelmans, Maarten van den Berge, Geertruida de Bock, Rozemarijn Vliegenthart

Summary: Predicted lung volumes based on the GLI model are used in pulmonary disease detection and monitoring. This study aimed to compare the GLI-2021 model predictions of TLC with CT-derived TLV.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Influenza season influence on outcome of new nodules in the NELSON study

H. L. Lancaster, M. A. Heuvelmans, G. H. de Bock, Y. Du, F. A. A. Mohamed Hoesein, K. Nackaerts, J. E. Walter, R. Vliegenthart, M. Oudkerk

Summary: We evaluated the impact of the influenza season on the outcome of new lung nodules in a lung cancer screening trial population. There was no statistically significant association between the influenza season and the resolution or persistence of new lung nodules. Hence, the management strategy for new nodules should not be influenced by the season in which they are detected.

SCIENTIFIC REPORTS (2023)

Article Geriatrics & Gerontology

Comparison of two frailty screening tools in older patients with colorectal cancer

Han Zhao, Xinlin Lu, Senshuang Zheng, Danmei Wei, Lizhong Zhao, Yuan Wang, Geertruida H. de Bock, Wenli Lu

Summary: This study aimed to compare the performance of Geriatric 8 (G8) and Korean Cancer Study Group Geriatric Score (KG-7) in identifying patients who need a full Geriatric Assessment. The results showed that G8 had higher accuracy and predictive ability compared to KG-7, making it more suitable for identifying patients in need of comprehensive assessment.

BMC GERIATRICS (2023)

Article Oncology

Identification of a methylation panel as an alternative triage to detect CIN3+in hrHPV-positive self-samples from the population-based cervical cancer screening programme

J. de Waard, A. Bhattacharya, M. T. de Boer, B. M. van Hemel, M. D. Esajas, K. M. Vermeulen, G. H. de Bock, E. Schuuring, G. B. A. Wisman

Summary: This study designed a methylation marker panel to detect CIN3+ in hrHPV-positive self-samples from the Dutch PBS as an alternative triage test for cytology.

CLINICAL EPIGENETICS (2023)

Article Public, Environmental & Occupational Health

The effect of extended participation windows on attendance at cervical cancer screening

Kelly M. Castaneda, Grigory A. Sidorenkov, Jolien de Waard, Marcel J. W. Greuter, Bert Van der Vegt, Inge M. C. M. de Kok, Albert G. Siebers, Karin M. Vermeulen, G. Bea A. Wisman, Ed Schuuring, Geertruida H. de Bock

Summary: This study aimed to evaluate the true participation rate of cervical cancer screening (CCS) by extending the time window for defining participation and to analyze the impact of sociodemographic determinants on participation delays. The findings showed that a 36-month window better reflected the actual participation rate and that delayed participation was associated with younger age, higher education, the high-risk human papillomavirus test-based program, and pregnancy. This suggests the importance of considering these factors when designing and promoting CCS programs.

PREVENTIVE MEDICINE REPORTS (2023)

Review Oncology

hr The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review

Keris Poelhekken, Yixuan Lin, Marcel J. W. Greuter, Bert van der Vegt, Monique Dorrius, Geertruida H. de Bock

Summary: The purpose of this review is to identify and analyze the assumptions made in modeling studies on the natural history of DCIS in women in order to improve estimates of overdiagnosis. The most important assumptions include the addition of non-progressive DCIS, classification of DCIS into three grades, and regression possibilities depending on age and grade. Other risk factors for progression of DCIS to IBC were also identified.

BREAST (2023)

Article Oncology

A comparison of cardiovascular and pulmonary morbidities and risk factors in breast cancer survivors compared to an age-matched female control group in the Lifelines prospective population cohort

D. S. Spoor, V. A. B. van den Bogaard, N. M. Sijtsema, P. van der Meer, G. H. de Bock, J. A. Langendijk, J. H. Maduro, A. P. G. Crijns

Summary: This study compares morbidity and risk factors between breast cancer survivors and age-matched controls, aiming to provide more insight into late treatment-related toxicities among breast cancer survivors. The results show that despite having a lower cardiovascular risk profile, breast cancer survivors still face the risk of late treatment-related toxicities.

BREAST (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Validation of an AI-based algorithm for measurement of the thoracic aortic diameter in low-dose chest CT

I. Iris Hamelink, E. Erik Jan de Heide, G. J. Gert Jan Pelgrim, T. C. Thomas Kwee, P. M. A. Peter van Ooijen, G. H. Truuske de Bock, R. Rozemarijn Vliegenthart

Summary: This study evaluated the performance of AI software for automatic thoracic aortic diameter assessment in low-dose, non-contrast chest CT. The results showed that the AI software can accurately measure aortic diameters and is comparable to human readers in terms of measurement consistency.

EUROPEAN JOURNAL OF RADIOLOGY (2023)

Article Multidisciplinary Sciences

Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study

Jacobien Niebuur, Judith M. Vonk, Yihui Du, Geertruida H. de Bock, Gerton Lunter, Paul F. M. Krabbe, Behrooz Z. Alizadeh, Harold Snieder, Nynke Smidt, Marike Boezen, Eva Corpeleijn

Summary: This study conducted in the northern Netherlands found that patients with multimorbidity are more likely to have unhealthy lifestyle factors such as physical inactivity, chronic stress, and inadequate sleep. These findings are of great importance for improving the lifestyle of patients with multiple chronic diseases.

PLOS ONE (2023)

Article Oncology

Randomized controlled study of pain education in patients receiving radiotherapy for painful bone metastases

Jenske Geerling, Yvette M. van der Linden, Natasja J. H. Raijmakers, Karin M. Vermeulen, Veronique E. M. Mul, Ellen J. M. de Nijs, Paulien G. Westhoff, Geertruida H. de Bock, Alexander de Graeff, Anna K. L. Reyners

Summary: This study investigated the additional effect of a nurse-led pain education program on pain control and quality of life for patients with bone metastases. The results showed that the pain education program reduced pain and led to faster pain control.

RADIOTHERAPY AND ONCOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Performance of Lung-RADS in different target populations: a systematic review and meta-analysis

Yifei Mao, Jiali Cai, Marjolein A. Heuvelmans, Rozemarijn Vliegenthart, Harry J. M. Groen, Matthijs Oudkerk, Marleen Vonder, Monique D. Dorrius, Geertruida H. de Bock

Summary: This systematic review and meta-analysis evaluated the performance of Lung-RADS (versions 1.0 and 1.1) in detecting lung cancer in different populations. The results showed that studies in high-risk populations had higher sensitivity and lower specificity than studies in general populations. Non-Asian studies tended to have better diagnostic performance than Asian studies. Limited evidence was available for the performance of Lung-RADS version 1.1 and its applicability to Asian populations.

EUROPEAN RADIOLOGY (2023)

Article Surgery

Postoperative muscle loss, protein intake, physical activity and outcome associations

Rianne N. M. Hogenbirk, Willemijn Y. van der Plas, Judith E. K. R. Hentzen, Laura van Wijk, Allard G. Wijma, Carlijn Buis, Alain R. Viddeleer, Geertruida H. de Bock, Cees P. van der Schans, Gooitzen M. van Dam, Schelto Kruijff, Joost M. Klaase

Summary: This study aimed to identify the incidence and risk factors for surgery-related muscle loss (SRML) after major abdominal surgery, and to study the impact of SRML on fatigue and survival. The study found that preoperative weight loss, postoperative nutritional intake, and physical activity were associated with SRML. SRML was also associated with decreased 1-year survival.

BRITISH JOURNAL OF SURGERY (2023)

Article Oncology

Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma

Diego de Miguel-Perez, Edward M. Pickering, Umberto Malapelle, William Grier, Francesco Pepe, Pasquale Pisapia, Gianluca Russo, Joseph A. Pinto, Alessandro Russo, Giancarlo Troncone, Melissa J. Culligan, Katherine A. Scilla, Ranee Mehra, Pranshu Mohindra, Oscar Arrieta, Andres F. Cardona, Marzia Del Re, Ashutosh Sachdeva, Fred R. Hirsch, Andrea Wolf, Joseph S. Friedberg, Christian Rolfo

Summary: In this study, genetic alterations in resectable pleural mesothelioma tissues and blood samples were analyzed, and it was found that high tissue tumor mutational burden, tissue median minor allele frequency, blood tumor mutational burden, and specific mutations were correlated with outcomes in patients with resected PM. These findings suggest that molecular profiling could help identify longer survivors in patients with resected PM.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial

Davide Melisi, Camilla Zecchetto, Valeria Merz, Giuseppe Malleo, Luca Landoni, Alberto Quinzii, Simona Casalino, Federica Fazzini, Marina Gaule, Camilla Pesoni, Luca Casetti, Alessandro Esposito, Giovanni Marchegiani, Cristiana Piazzola, Mirko D'Onofrio, Riccardo de Robertis, Armando Gabbrielli, Laura Bernardoni, Stefano F. Crino, Silvia Pietrobono, Claudio Luchini, Camillo Aliberti, Guido Martignoni, Stefano Milleri, Giovanni Butturini, Aldo Scarpa, Roberto Salvia, Claudio Bassi

Summary: This study evaluated the safety and activity of liposomal irinotecan in the perioperative treatment of resectable pancreatic ductal adenocarcinoma (rPDAC) patients. The results showed that NALIRIFOX has manageable and active outcomes, and should be further investigated in randomized trials comparing it to standard upfront surgery followed by adjuvant therapy.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

Eric Jonasch, Todd M. Bauer, Kyriakos P. Papadopoulos, Elizabeth R. Plimack, Jaime R. Merchan, David F. Mcdermott, M. Dror Michaelson, Leonard J. Appleman, Ananya Roy, Rodolfo F. Perini, Yanfang Liu, Toni K. Choueiri

Summary: After a median follow-up of 41.2 months, belzutifan monotherapy demonstrated durable antitumor activity in patients with advanced ccRCC and acceptable safety.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Impact of colorectal cancer screening on survival after metachronous metastasis

Patricia A. H. Hamers, Geraldine R. Vink, Marloes A. G. Elferink, Leon M. G. Moons, Cornelis J. A. Punt, Anne M. May, Miriam Koopman

Summary: Screen-detection of the primary tumor is associated with longer overall survival after metachronous metastasis.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY)

Camilla Nero, Nicolo Bizzarri, Stefano Di Berardino, Francesca Sillano, Giuseppe Vizzielli, Francesco Cosentino, Virginia Vargiu, Pierandrea De Iaco, Anna Myriam Perrone, Enrico Vizza, Benito Chiofalo, Stefano Uccella, Fabio Ghezzi, Luigi Carlo Turco, Giacomo Corrado, Diana Giannarelli, Tina Pasciuto, Gian Franco Zannoni, Anna Fagotti, Giovanni Scambia

Summary: This study evaluates the sensitivity and specificity of sentinel-lymph-node mapping compared to systematic lymphadenectomy in detecting lymph node metastasis in early stage ovarian cancer. The results show that sentinel-lymph-node mapping did not reach the expected sensitivity, but ultra-staging protocol improved the accuracy of diagnosis for patients.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma

Adriana Hepner, Judith M. Versluis, Roslyn Wallace, Clara Allayous, Lauren Julia Brown, Claudia Trojanielloh, Camille Lea Gerardi, Yanina J. L. Jansenj, Prachi Bhave, Bart Neyns, Andrew Haydon, Olivier Michielin, Joanna Manganan Oliver Klein, Alexander N. Shoushtari, Allison Betof Warner, Paolo Antonio Ascierto, Jennifer Leigh McQuade, Matteo S. Carlino, Lisa Zimmer, Celeste Lebbe, Douglas B. Johnson, Shahneen Sandhu, Victoria Atkinson, Christian U. Blank, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies

Summary: Acquired resistance to PD-1 therapy in melanoma is mainly oligometastatic, and patients may have a favorable survival outcome following salvage treatment.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study

Savannah Roy, Stephanie Lakritz, Anna R. Schreiber, Elizabeth Molina Kuna, Cathy J. Bradley, Lavanya Kondapalli, Jennifer R. Diamond

Summary: This study evaluates major adverse cardiovascular events (MACE) in older women with TNBC treated with anthracycline and taxane-based chemotherapy (ATAX) compared to taxane-based chemotherapy (TAX). The results show that ATAX does not increase the risk of MACE and there is no difference in survival between patients who received TAX and ATAX.

EUROPEAN JOURNAL OF CANCER (2024)

Letter Oncology

Osimertinib-induced urticarial vasculitis in a patient with lung cancer: A rare cutaneous toxicity

Pei-Chun Weng, Yau-Li Huang, Chun-Yu Cheng

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Deep learning based histological classification of adnex tumors

Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank

Summary: This study highlights the enormous potential of artificial intelligence in pathology, showing that it can aid in the identification of rare cutaneous adnexal tumors and potentially become a standard tool in routine diagnostics.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

Casper W. F. van Eijck, Gaby Strijk, Eveline E. Vietscha, Fleur van der Sijde, Maaike Verheij, Dana A. M. Mustafa, Madelief Vinkc, Joachim G. J. V. Aerts, Casper H. J. van Eijck, Marcella Willemsen

Summary: The study reveals that FOLFIRINOX has immunomodulatory effects, suggesting its potential in immune-based combination therapies for pancreatic cancer. Additionally, certain plasma proteins hold promise as circulating predictive biomarkers for early prediction of FOLFIRINOX response in patients with pancreatic cancer.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases

Marwan Fakih, Chongkai Wang, Jaideep Sandhu, Jian Ye, Colt Egelston, Xiaochen Li

Summary: This study explores the impact of metastatic sites on treatment outcomes for chemotherapy-refractory colorectal cancer patients. It found that patients with liver or peritoneal metastases had poor treatment outcomes, while those with lung-only metastases showed significant response. The presence of concurrent lymph node or other extrahepatic metastatic disease diminished treatment response in patients with lung metastases. Future checkpoint inhibitor trials should stratify patients based on metastatic locations.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Peptide absent sequences emerging in human cancers

Georgios Christos Tsiatsianis, Candace S. Y. Chan, Ioannis Mouratidis, Nikol Chantzi, Anna Maria Tsiatsiani, Nelson S. Yee, Apostolos Zaravinos, Verena Kantere, Ilias Georgakopoulos-Soares

Summary: The study reveals that nullpeptides can serve as biomarkers for cancer detection and treatment, particularly in highly recurrent cancer patients. These nullpeptides primarily occur in highly expressed genes, particularly in specific loci of oncogenes and tumor suppressors. Recurrent nullpeptides are more likely to be found in neoantigens, which play a significant role in immunotherapy.

EUROPEAN JOURNAL OF CANCER (2024)